TPC Robotics Establishes AI Robotics Research Institute, Accelerates Expansion of Robotics Business

TPC Robotics, a specialist in core AI autonomous manufacturing technologies and robotic components, is accelerating its transition into the robotics business by establishing an AI robotics research institute. The company plans to separate its existing robotics development team from its current research organization and strengthen its AI-based robotics technology development capabilities by recruiting additional experts.

On June 15, TPC Robotics announced that it had completed the establishment of its AI robotics research institute in accordance with the development roadmap outlined in the "Strategic Cooperation Agreement on Joint Development and Production" signed in April with Zhejiang Hechuan Humanoid Robot Co., Ltd. (HCBOT), a Chinese humanoid robotics technology company. The company is also carrying out practical tasks to expand its robotics business lineup.

The company explained that, while it has been operating its own laboratory for the development of pneumatic and motion technologies, it established a separate AI robotics organization to strengthen its robotics drive and control technology capabilities, which are essential for expanding its robotics business. TPC Robotics has also completed discussions to broaden the scope of its collaboration with HCBOT, alongside efforts to secure professional talent.

A TPC Robotics representative stated, "To enhance our competitiveness in the robotics business, we have newly established the AI robotics research institute and are focusing on securing related development capabilities. In August, we plan to launch our own brand of robotic actuators and begin full-scale sales activities targeting companies developing industrial and humanoid robots."

The representative added, "Within this year, we aim to introduce differentiated robotic automation cell solutions through the AI robotics research institute, develop and launch AI-based smart actuators, and secure integrated solutions combining actuator and control technologies to further expand our business."

In March, TPC Robotics changed its company name from TPC Mechatronics to its current name and has been pursuing a business structure shift toward becoming a robotics company. The establishment of the AI robotics research institute is described as a strategic move not only to expand its robotics-related product portfolio but also to add software capabilities to its traditionally hardware-focused business.

The company also plans to expand its AI and robotics technology convergence business through joint development with affiliates and partner companies in the bio and mechatronics fields, along with the establishment of the AI robotics research institute.

As a first step, TPC Robotics will jointly develop next-generation AI rehabilitation robots with HuKA System, a specialist in gait rehabilitation robots. HuKA System develops and supplies gait rehabilitation robots that incorporate its own embedded PCB, load cell, and encoder-based robot control algorithms. Its products are registered as medical devices in Korea, with the U.S. Food and Drug Administration (FDA), Vietnam, and the United Arab Emirates, demonstrating recognized technological capability.

In particular, HuKA System’s "robot-assisted orthopedic exercise device" is registered as a Class 3 medical device with coverage under medical reimbursement by the Ministry of Food and Drug Safety. Following exports to hospitals in Vietnam last year, exports and deliveries to major institutions such as the Indian government’s Rehabilitation Research and Training Institute (RRTI) and AIIMS are scheduled for this month.

TPC Robotics plans to incorporate AI functionality into HuKA System’s rehabilitation robot technology to provide customized data for patients with central nervous system disorders such as stroke and deliver optimized rehabilitation services based on each patient’s condition.

In addition, TPC Robotics will collaborate with T1Bio, a specialist in molecular diagnostic devices, to develop an all-in-one diagnostic device for medical and public health use with enhanced AI capabilities.

T1Bio was selected for the "2026 AI Application Product Rapid Commercialization Support Program," organized by the Ministry of Trade, Industry and Energy, with its project for an "Agent AI-based rapid food safety inspection system," and will conduct research and development for one year. Ourhome, a food company, will participate as a joint development partner and demand company.

This product is a system that fully automates the PCR-based pre-processing process for detecting foodborne bacteria and rapidly provides results on site using AI. TPC Robotics plans to participate directly in AI development and future mass production processes, further strengthening its business competitiveness in the medical and bio sectors.

Centered on the AI robotics research institute, TPC Robotics will combine robotic drive and control technology with AI software capabilities, expand its business areas from industrial robots to rehabilitation robots and diagnostic devices, and accelerate its transformation into a comprehensive robotics company.

This content was produced with the assistance of AI translation services.